Cognitive Effects of a Dietary Supplement With PQQ, GABA, Caffeine, and B-Vitamins in Healthy Postmenopausal Women: A Randomized Controlled Trial
NCT06748989 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70
Last updated 2025-09-08
Summary
Various food supplements have been shown to improve cognitive function. However, there is limited data on the impact of these supplements on postmenopausal women. Millions of women experience difficulty with concentration, and memory lapses during menopause. Research shows that up to 60% of women report cognitive changes related to menopause, severely impacting their quality of life and professional performance. Women are significantly more likely to develop dementia and other cognitive dysfunction. The specially formulated Cortexium with four key ingredients aims to support cognitive function in women:
* PQQ (Pyrroloquinoline Quinone) is a redox coenzyme with high antioxidant potential and is considered to affect the brain function by increasing mitochondrial production and activation, nerve cell protection, and enhanced production of nerve growth factor.
* GABA (gamma-aminobutyric acid) is an important neurotransmitter that helps induce calm and relaxation in the brain. Its positive effects include reducing stress and anxiety, which promotes mental clarity and concentration, thus enhancing mental performance. Additionally, it can help combat fatigue by supporting restful sleep, which, in the long term, boosts brain function efficiency.
* B-VITAMINS (B1, B2, B3, B5, B6, B7, B9, B12) are essential for brain function and energy production. They support the synthesis of neurotransmitters that improve mood, memory, and concentration, and help combat stress and mental fatigue. Together, they contribute to protecting brain cells and maintaining cognitive performance.
* CAFFEINE: The stimulating and invigorating effects of caffeine on the brain and nervous system have been known for centuries. Caffeine is a mild psychostimulant with invigorating effects. It also alleviates symptoms of fatigue and enhances work capacity. Moreover, moderate amounts of caffeine are known to have a stimulating effect on the cerebrocortical fields responsible for thinking: it enhances mental activity, improves cognitive functions, and accelerates mental associations. In this way, caffeine's stimulating effect can also lead to an improved sense of well-being Our aim is test the hypothesis that Cortexium dietary supplement improves cognitive function in postmenopausal women.
Conditions
- Cognitive Function and Memory
Interventions
- DIETARY_SUPPLEMENT
-
Cortexium food supplement
Cortexium (a specially formulated dietary supplement with pyrroloquinoline quinone, γ-aminobutyric acid and B vitamins).
- DIETARY_SUPPLEMENT
-
Placebo food supplement
Placebo food supplement is completely identical weight and outlook capsule to Cortexium, with 50% microcrystalline cellulose and 50% starch.
Sponsors & Collaborators
-
FEMPHARMA Kft.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-05-20
- Primary Completion
- 2025-10-30
- Completion
- 2025-11-30
Countries
- Hungary
Study Locations
More Related Trials
-
Benefits of Nicotinamide Riboside Upon Cognition and Sleep
NCT05500170 ·Status: RECRUITING ·Phase: NA
-
Efficacy and Safety of the Herbal Medicine Sominex ® (Passiflora Incarnata L., Valeriana Officinalis L. and Crataegus Oxyacantha L.), Manufactured by the Laboratory EMS S / A in Patients With Psychophysiological Insomnia
NCT01100645 ·Status: UNKNOWN ·Phase: PHASE3
-
Modafinil Treatment for Sleep/Wake Disturbances in Older Adults
NCT00626210 ·Status: TERMINATED ·Phase: PHASE4
-
Comparing Digital Therapy, Trazodone, and Daridorexant for Menopause-Related Insomnia Symptoms
NCT07136415 ·Status: RECRUITING ·Phase: PHASE4
-
Exogenous Melatonin in Postmenopausal Women with Insomnia
NCT05440734 ·Status: TERMINATED ·Phase: NA
-
Impact of Nutritional Supplementation on Sleep Quality and Gut Microbiome Composition in Older Adults
NCT04078724 ·Status: COMPLETED ·Phase: NA
-
Effect of Rozerem on Sleep Among People With Traumatic Brain Injury
NCT01207050 ·Status: UNKNOWN ·Phase: PHASE4
-
Feasibility Study on the Use of Redormin®500 on Day-time Cognition
NCT05684523 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Valerian on Insomnia in Menopausal Women
NCT05185219 ·Status: RECRUITING ·Phase: NA
-
The Effects of Modafinil on Waking Function and on Sleep in Individuals With Primary Insomnia
NCT00124384 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of a Hypocretin/Orexin Antagonist on Neurocognitive Performance
NCT01243060 ·Status: COMPLETED ·Phase: NA
-
Study of the Efficacy of Dietary Supplementation in Targeting Sleep Quality (NutriSom-01B)
NCT07200167 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Efficacy and Safety of Oral Midazolam Used for the Delivery of Care in Elderly Patient With Neurocognitive Disorders and Refusing Care.
NCT06638710 ·Status: RECRUITING ·Phase: PHASE2
-
Effects Of GW679769 On Sleep Onset And Maintenance,And Next Day Functioning In The Elderly And Non-elderly With Primary Insomnia
NCT00280436 ·Status: COMPLETED ·Phase: PHASE2
-
The Treatment of Insomnia in Symptomatic Peri- and Postmenopausal Women
NCT00374192 ·Status: COMPLETED ·Phase: NA
-
How do Sleeping Pills Affect Pain in the Brain?
NCT00414037 ·Status: TERMINATED ·Phase: PHASE4
-
A Study of the Effect of Daridorexant on Nighttime Body Posture, the Noise Level Required to Wake up, and the Ability to Remember Words Previously Presented
NCT05702177 ·Status: COMPLETED ·Phase: PHASE1
-
Memory Consolidation in Pharmacologically Enhanced Naps
NCT00777829 ·Status: COMPLETED ·Phase: NA
-
Study to Investigate Effects of a Herbal Drug Compared to Placebo on Sleep
NCT00997256 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Efficacy and Safety of Armodafinil as Treatment for Patients With Excessive Sleepiness Associated With Mild or Moderate Closed Traumatic Brain Injury
NCT00893789 ·Status: TERMINATED ·Phase: PHASE3
-
A Study of ORX142 in Healthy Adult Subjects, Including Subjects 18 to 80 Years of Age
NCT07082829 ·Status: RECRUITING ·Phase: PHASE1
-
Safety Study of the Effect of Scelectium Tortuosum (as Zembrin®)in Aged Normals
NCT01805518 ·Status: COMPLETED ·Phase: PHASE1
-
Treating Insomnia and Improving Metabolic Health in Midlife Women With Insomnia
NCT05593653 ·Status: COMPLETED ·Phase: PHASE4
-
Acute Effects of Gabapentin in Sleep Parameters and Hormonal Release During Sleep in Older Men
NCT02599701 ·Status: TERMINATED ·Phase: PHASE4
-
Exogenous Melatonin in Intensive Care Unit Chronodisruption
NCT03708341 ·Status: RECRUITING ·Phase: PHASE3